A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center

BACKGROUND: /Objectives: Obesity is a risk factor for COVID-19 infection severity and mortality. Anti-obesity medications (AOM) are effective for weight loss. However, weight loss outcomes with AOM during the COVID-19 pandemic are yet to be described. SUBJECTS: /Methods: Between January 1, 2016, and...

Descripción completa

Detalles Bibliográficos
Autores principales: De la Rosa, Alan, Ghusn, Wissam, Sacoto, Daniel, Campos, Alejandro, Cifuentes, Lizeth, Feris, Fauzi, Busebee, Bradley, Calderon, Gerardo, Acosta, Andres, Hurtado, Maria D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714128/
https://www.ncbi.nlm.nih.gov/pubmed/37990666
http://dx.doi.org/10.1016/j.obpill.2022.100046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714128/
https://www.ncbi.nlm.nih.gov/pubmed/37990666
http://dx.doi.org/10.1016/j.obpill.2022.100046

Ejemplares similares